DUBAI-INTERNET-CITY
20.10.2015 13:21:15 CEST | Business Wire | Press release
Dubai Internet City (DIC) , the official partner for the Smart City App Hack, has announced the competition’s 10 finalists; Boxit.com, Ithal, Einvite, Carpool Arabia, World Spotlight, D2D Auto Services, LupUp, GPSShield, MyGreenRank and App3ad. The competition is part of DIC’s role as a Strategic Partner for Smart Dubai, to support the development of UAE start-ups and app developers and bring together the tech community and foster innovation and creativity.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151020005876/en/
Over the past five months, developers and entrepreneurs have had the chance to be involved in the building of a truly Smart City and have created and developed apps, mentored by a global team of tech experts. Applicants were invited to submit app ideas based around five Smart themes; Urban Mobility, Energy and Emissions, Culture and Tourism, Retail and Shopping and Collaborative City, ahead of selection on 3 October.
The winning team will be awarded a trip to Barcelona to pitch their app at the Smart City Expo in November, as well as in5 membership, and second and third place will be awarded four months of membership at in5, and the chance to be selected as one of the finalists to pitch their apps in Barcelona. The winner of the Smart City Expo will be invited to pitch at the MasterCard Masters of Code in Silicon Valley.
Majed Al Suwaidi, Managing Director of Dubai Internet City and Dubai Outsource Zone said;
“The Smart City App Hack competition is part of our wider focus on supporting the development of UAE start-ups, entrepreneurs, mobile application and web developers. Competitions such as this are instrumental in achieving Dubai’s wider smart objectives and will contribute to the government’s vision to make Dubai the smartest place in the world by 2017.”
To register for the competition, please visit http://dubai.smartcityapphack.com/
About Dubai Internet City
Dubai Internet City (DIC), part of TECOM Group, a member of Dubai Holding, is the Middle East and North Africa’s largest ICT hub. Since the year 2000, DIC has successfully developed a prosperous ecosystem for technology organisations and today is home to Fortune 500 listed companies and multinationals as well as some of the region’s most dynamic and successful technology SMEs and start-ups from all elements of the ICT value chain.
DIC provides a wide range of facilities including state-of-the-art offices, a robust IT infrastructure, 24-hour security, retail services and hotels, spread across the business park’s unique and tranquil landscape; an environment that helps ICT businesses develop, innovate and grow.
For more information, please visit: www.dubaiinternetcity.com .
*Source: ME NewsWire
View source version on businesswire.com: http://www.businesswire.com/news/home/20151020005876/en/
Contact:
For Dubai Internet City
Alexa Hooft Graafland, +971-55-559-7404
AHooftGraafland@bell-pottinger.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom